Boston Scientific launches new coronary imaging catheter
7 April 2009
Boston Scientific Corporation (NYSE:BSX) has launched its iCross
coronary imaging catheter, a product designed to improve the
deliverability of the company's market-leading intravascular ultrasound
(IVUS) technology, the iLab ultrasound imaging system.
IVUS technology enables physicians to see detailed images inside the
heart and coronary arteries. The company said the iCross catheter would
be available immediately in the United States.
"Boston Scientific's iCross coronary imaging catheter is a powerful
tool for visualizing coronary intravascular pathology, especially in
patients with complex coronary artery disease," said Augusto Pichard,
M.D., Director, Cardiac Catheterization Lab, Washington Hospital Center.
"The combination of the iCross' outstanding image quality and excellent
deliverability should help physicians better identify lesion
"This latest advance builds on the success of our existing Atlantis
SR Pro catheter," said Hank Kucheman, Senior Vice President and Group
President, Cardiovascular for Boston Scientific. "We expect that the
improvements iCross offers to physicians and their patients will help
further solidify our leadership in intravascular ultrasound."
The iCross catheter features a Bioslide hydrophilic coating that has
been shown in bench tests to provide a 28% improvement in pushability in
challenging human anatomy.
Bookmark this page